Jonathan Katz
Impact in
- Neurology top 0.1%
- Amyotrophic Lateral Sclerosis Research
- Peripheral Neuropathies and Disorders
- Myasthenia Gravis and Thymoma
- Speech and Hearing top 2%
Papers in
- Neurology 111
- Amyotrophic Lateral Sclerosis Research 66
- Peripheral Neuropathies and Disorders 36
- Myasthenia Gravis and Thymoma 11
- Co-authors
- Richard J. Barohn (31 shared papers)Anthony A. Amato (10 shared papers)David Saperstein (21 shared papers)Susan C. Woolley (10 shared papers)Gil I. Wolfe (15 shared papers)Carlayne E. Jackson (7 shared papers)Wilson W. Bryan (9 shared papers)Hiroshi Mitsumoto (10 shared papers)
- Journals
- Neurology (27 papers)Muscle & Nerve (19 papers)Neurologic Clinics (9 papers)Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (8 papers)The Lancet Neurology (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Jonathan Katz
124 papers receiving 8.5k citations
Jonathan Katz's Hit Papers
Peers
Comparison fields: 5 of 120
- Neurology 6.1k
- Neurology 255
- Speech and Hearing 106
- Physiology 476
- Cellular and Molecular Neuroscience 286
Countries citing papers authored by Jonathan Katz
This map shows the geographic impact of Jonathan Katz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Katz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Katz more than expected).
Fields of papers citing papers by Jonathan Katz
This network shows the impact of papers produced by Jonathan Katz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Katz. The network helps show where Jonathan Katz may publish in the future.
Co-authors
The 25 scholars most cited alongside Jonathan Katz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Drug, nutritional, and respiratory therapies (an evidence-based review)[RETIRED] Hit paper breakdown → | 2009 | 647 |
| 2 | Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study Hit paper breakdown → | 2017 | 632 |
| 3 | Genome-Wide Analyses Identify KIF5A as a Novel ALS Gene Hit paper breakdown → | 2018 | 539 |
| 4 | Practice Parameter update: The care of the patient with amyotrophic lateral sclerosis: Multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review) Hit paper breakdown → | 2009 | 516 |
| 5 | Trial of Sodium Phenylbutyrate–Taurursodiol for Amyotrophic Lateral Sclerosis Hit paper breakdown → | 2020 | 415 |
| 6 | 2001 | 327 | |
| 7 | 2008 | 280 | |
| 8 | 2009 | 271 | |
| 9 | 2000 | 256 | |
| 10 | 2014 | 222 | |
| 11 | 2008 | 213 | |
| 12 | 1999 | 210 | |
| 13 | 2007 | 196 | |
| 14 | 2009 | 192 | |
| 15 | 1996 | 190 | |
| 16 | 2010 | 180 | |
| 17 | Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study Hit paper breakdown → | 2023 | 178 |
| 18 | 2020 | 177 | |
| 19 | 2019 | 176 | |
| 20 | 2020 | 136 |
About Jonathan Katz
Jonathan Katz is a scholar working on Neurology, Physiology, Radiology, Nuclear Medicine and Imaging, Cellular and Molecular Neuroscience and Neurology, having authored 131 papers that have together received 9k indexed citations. Recurring topics across this work include Amyotrophic Lateral Sclerosis Research (66 papers), Peripheral Neuropathies and Disorders (36 papers), Myasthenia Gravis and Thymoma (11 papers), Inflammatory Myopathies and Dermatomyositis (4 papers), Muscle Physiology and Disorders (4 papers), Hereditary Neurological Disorders (3 papers), Peripheral Nerve Disorders (3 papers) and Respiratory Support and Mechanisms (2 papers). The work is most often cited by research in Neurology (6.1k citations), Neurology (255 citations), Speech and Hearing (106 citations), Physiology (476 citations) and Cellular and Molecular Neuroscience (286 citations). Jonathan Katz has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Richard J. Barohn, Anthony A. Amato, David Saperstein, Susan C. Woolley, Gil I. Wolfe, Carlayne E. Jackson, Wilson W. Bryan, Hiroshi Mitsumoto, Richard J. Barohn and Edward J. Kasarskis. Their work appears in journals such as Neurology, Muscle & Nerve, Neurologic Clinics, Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration and The Lancet Neurology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.